New Perspective Fund

New Perspective Fund · Series S000009613 · 21 share classes

Equity fund · 98% stocks
One fund, 21 share classes:ANWPXRNPAXRNPBXRNPCXRNPEXRNPFXNPFCXNPFFXCNPAXCNPCXCNPEXCNPFXANWFXRNPGXRPEBXRNPHXFNPFXTPNFXTNPFXFFPNXFNFPX
$170.36B NAV
289 positions · as of 2026-06-30 · filed 2026-08-27
data updated 2026-09-08

Fund profile

As filed in the prospectus · 2025 Q4

The funds investment objective is to provide you with long-term growth of capital.

Strategy · summarised

The fund invests in common stocks of companies worldwide, selected by its investment adviser for attractive valuation and long-term growth potential. Portfolio management is divided among multiple managers, each overseeing segments of the fund's assets. Securities are sold when they no longer meet the adviser's investment criteria.

Expenses
0.40% 1.51%across 21 share classes
Share classExpense ratio
ANWPX0.71%
RNPAX1.49%
RNPBX1.49%
RNPCX1.05%
RNPEX0.75%
RNPFX0.45%
NPFCX1.47%
NPFFX0.77%
CNPAX0.74%
CNPCX1.51%
CNPEX0.98%
CNPFX0.83%
ANWFX0.51%
RNPGX0.40%
RPEBX1.20%
RNPHX0.55%
FNPFX0.40%
TPNFX0.76%
TNPFX0.72%
FFPNX0.50%
FNFPX0.45%

Portfolio turnover 23.00% · as of 2025 Q4

Allocation

Asset groups · long / short shown separately, never netted · 2026 Q2

100.18%
of net assets
Stocks97.90%
Cash & short-term2.28%

Latest quarter

What changed since the fund's previous filing

2026Q2 vs 2026Q1: 28 new16 exited

Largest new: CSCO, KIOXIA HOLDINGS CORP, PANASONIC HOLDINGS CORP, WISE GROUP PLC, ANET, STANDARD CHARTERED PLC, MILLICOM INTL CELLULAR SA, RESONAC HOLDINGS CORP

Largest exited: WISE PLC, GS, HD, COO, BIOMERIEUX, ECL, HYUNDAI MOTOR CO, ASCENDIS PHARMA AS

Return profile

Chart:

Total return as filed — price change plus distributions reinvested · trailing figures to Apr 2026

Share class1-year3-year5-yearVolWorst fall
+23.68%+61.97%+46.67%13.88%-10.16%
+22.71%+58.28%+41.19%13.88%-10.34%
+22.74%+58.26%+41.10%13.87%-10.31%
+23.26%+60.37%+44.27%13.89%-10.23%
+23.64%+61.84%+46.47%13.89%-10.16%
+24.01%+63.30%+48.69%13.89%-10.09%
+22.73%+58.36%+41.25%13.86%-10.34%
+23.60%+61.69%+46.25%13.90%-10.18%
+23.66%+61.84%+46.42%13.90%-10.16%
+22.70%+58.16%+40.90%13.87%-10.35%
+23.34%+60.67%+44.68%13.89%-10.23%
+23.84%+62.63%+47.66%13.88%-10.12%
+23.92%+63.01%+48.24%13.88%-10.12%
+24.06%+63.52%+49.01%13.89%-10.09%
+23.09%+59.66%+43.16%13.89%-10.26%
+23.88%+62.78%+47.93%13.89%-10.12%
+24.04%+63.50%+49.03%13.88%-10.09%
+23.93%+62.96%+48.17%13.90%-10.11%
+23.97%+63.24%+48.60%13.89%-10.09%
+23.94%+63.02%+48.29%13.89%-10.10%
+23.99%+63.27%+48.60%13.88%-10.08%

These classes hold the same portfolio, so the 8.13pp spread over 5 years is the cost difference between them — roughly 1.63pp a year — not a difference in what they own.

Cumulative return· Jul 2023 – Apr 2026

May 2026 and Jun 2026 have been filed since the trailing figures were struck, so they are not in the table above or the curve — every figure here shares one cut-off, which is what makes them comparable with other funds.

Holdings

By % of NAV · equity positions carry filed share counts · every resolvable issuer links to its company page

Issuer%NAVValue
TAIWAN SEMICONDUCTOR MANUFACTURING CO LTD4.88%$8.31B
META PLATFORMS INCMETA3.26%$5.55B
NVIDIA CORPNVDA3.14%$5.35B
BROADCOM INCAVGO3.13%$5.33B
TESLA INCTSLA2.79%$4.75B
CAPITAL GROUP CENTRAL CASH FUNDCMQXX2.31%$3.94B
MICROSOFT CORPMSFT2.05%$3.49B
ASML HOLDING NV1.95%$3.31B
SK HYNIX INC1.91%$3.26B
ASTRAZENECA PLC1.85%$3.16B
Showing 10 of 289Sign in to see more

Reported price is the fund's own reported value divided by its own reported shares at 2026-06-30 — not a live quote, and not what the fund paid.

Top 10 positions are 27.27% of net assets, top 25 46.06%, across 285 issuers.

See more of this fund's book

More positions with filed share counts, and the quarter-over-quarter change list rather than the largest few — free with an account, no card required.

Sign in free